Invention Grant
- Patent Title: Methods for screening compounds for treating or preventing a viral infection or a virus-related condition
-
Application No.: US15552660Application Date: 2016-02-19
-
Publication No.: US10718770B2Publication Date: 2020-07-21
- Inventor: Didier Scherrer , Aude Garcel , Noelie Campos , Jamal Tazi , Audrey Vautrin , Florence Mahuteau , Romain Najman , Pauline Fornarelli
- Applicant: ABIVAX , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , INSTITUT CURIE , UNIVERSITE DE MONTPELLIER
- Applicant Address: FR Paris FR Paris FR Paris FR Montpellier
- Assignee: ABIV AX,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT CURIE,UNIVERSITE DE MONTPELLIER
- Current Assignee: ABIV AX,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT CURIE,UNIVERSITE DE MONTPELLIER
- Current Assignee Address: FR Paris FR Paris FR Paris FR Montpellier
- Agency: Oliff PLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@59c63c1
- International Application: PCT/EP2016/053533 WO 20160219
- International Announcement: WO2016/135053 WO 20160901
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/569
Abstract:
The present invention relates to a method for screening a compound useful for treating or preventing a viral infection or a virus-related condition in an individual, comprising at least the steps of: a) determining the ability of a candidate compound to promote the interaction between CBP20 and CBP80 in a sample, and b) selecting the candidate compound that is determined to promote said interaction at step a). The present invention further relates to a method for screening a compound useful for treating or preventing a viral infection or virus-related condition in an individual, comprising at least the steps of: a) determining the ability of a candidate compound to interact with CBP20 or CBP80 in a sample, and b) selecting the candidate compound that is determined to interact with CBP20 or CBP80 at step a).
Public/Granted literature
Information query
IPC分类:
